|
MTA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.57970000000441E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.94653999999739E-05 |
| Normal-vs-Stage2 |
7.141800E-03 |
| Normal-vs-Stage3 |
1.104010E-02 |
| Normal-vs-Stage4 |
1.439820E-03 |
| Stage1-vs-Stage2 |
2.846000E-01 |
| Stage1-vs-Stage3 |
7.962100E-02 |
| Stage1-vs-Stage4 |
6.461200E-01 |
| Stage2-vs-Stage3 |
8.116600E-01 |
| Stage2-vs-Stage4 |
6.007200E-01 |
| Stage3-vs-Stage4 |
4.297000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.65820000000272E-05 |
| Normal-vs-AfricanAmerican |
3.143700E-03 |
| Normal-vs-Asian |
1.191220E-04 |
| Caucasian-vs-AfricanAmerican |
8.407800E-01 |
| Caucasian-vs-Asian |
4.038400E-01 |
| AfricanAmerican-vs-Asian |
7.018000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.028590E-04 |
| Normal-vs-Female |
1.576120E-04 |
| Male-vs-Female |
5.659200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.19409999996567E-06 |
| Normal-vs-Age(41-60Yrs) |
1.142490E-03 |
| Normal-vs-Age(61-80Yrs) |
1.162180E-02 |
| Normal-vs-Age(81-100Yrs) |
2.584100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.335900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.313900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.507800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.477000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.425600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.719200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.218110E-02 |
| Classical-VS-Follicular |
8.793400E-04 |
| Classical-VS-Other |
2.811600E-02 |
| Classical-VS-Normal |
1.13619999964065E-07 |
| Tall-VS-Follicular |
9.559600E-01 |
| Tall-VS-Other |
4.532800E-01 |
| Tall-VS-Normal |
1.708160E-01 |
| Follicular-VS-Other |
4.392800E-01 |
| Follicular-VS-Normal |
7.235800E-02 |
| Other-VS-Normal |
9.691000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.222800E-04 |
| Normal-vs-N1 |
2.071600E-02 |
| N0-vs-N1 |
5.379200E-01 |
|
|
